NRC Health reported flat revenue and decreased net income and diluted earnings per share for the third quarter of 2022. Revenue was $37.7 million, net income was $8.3 million, and diluted earnings per share was $0.33.
Revenue remained approximately flat compared to the 2021 quarter due to the phase out of Canadian operations and a decline in other non-core offerings.
Investments in innovation initiatives, marketing, and associate retention increased operating expenses for the quarter.
The company paid $5.9 million in dividends and $3.6 million related to share repurchases during the quarter.
Diluted earnings per share decreased to $0.33 for the quarter ended September 30, 2022, from diluted earnings per share of $0.38 for the quarter ended September 30, 2021.
The press release contains forward-looking statements subject to risks and uncertainties as outlined in the company's filings with the Securities and Exchange Commission.
Analyze how earnings announcements historically affect stock price performance